DYRAX ANTIMALARIA
DYRAX ANTIMALARIA is an efficient drug used in the treatment of uncomplicated malaria. It contains Dihydroartemisinin and Piperaquine as its active ingredients.
Key Information
- Active Ingredients: Dihydroartemisinin and Piperaquine
Health Benefits
DYRAX ANTIMALARIA is used for the following health benefits:
- Treatment of uncomplicated falciparum malaria
- Treatment of uncomplicated malaria due to other Plasmodium species when chloroquine cannot be used
- Completion treatment following parenteral therapy for severe malaria
Administration and Dosage
Oral Administration: Dyrax Tablets and Suspension should be given daily for 3 days. Patients should follow the doctor’s instructions. The recommended dosages according to body weight are provided below:
- 5 to < 8 kg: ½ tablet once daily for 3 days
- 8 to < 11 kg: 1½ tab of 20mg/160mg
- 11 to < 17 kg: 1 tablet daily for 3 days
- 17 to < 25 kg: 1.5 tablets daily for 3 days
- 25 to < 36 kg: 2 tablets daily for 3 days
- 36 to < 60 kg: 3 tablets daily for 3 days
- 60 to < 80 kg: 4 tablets daily for 3 days
- >80 kg: 5 tablets daily for 3 days
Precaution and Side Effects
DYRAX ANTIMALARIA should not be used for women during the first 3 months of pregnancy. Do not administer in the event of cardiac disorders (bradycardia, heart rhythm disorders, congestive heart failure).
Do not combine with drugs that prolong the QT interval, such as amiodarone, other antimalarials, antipsychotics, fluconazole, fluoroquinolones, hydroxyzine, macrolides, ondansetron, etc.
Administer with caution to patients > 60 years or with renal or hepatic impairment.
May cause cardiac disorders (QT prolongation, tachycardia); rarely, gastrointestinal disturbances, pruritus, hepatic disorders, joint and muscle pain.
Always follow your doctor's advice and instructions for proper use and to manage potential side effects.